Should a clinic screen for both anxiety and depression?
Last updated
There is a strong case for it. Anxiety disorders are common in primary care, often ride along with depression, and are frequently missed. In one large study, about one in five patients had an anxiety disorder, and many were going untreated. Screening for anxiety alongside depression catches people a depression screen alone would overlook.
What does this mean for your clinic?
Most clinics already screen for depression. The question this study raises is whether stopping there leaves too much on the table. Its answer is that anxiety is about as common, about as impairing, and much less likely to be caught, so a depression screen alone misses a large and treatable group of your patients.
The overlap is the practical point. Anxiety and depression are not tidy, separate boxes. In this study the two traveled together often, and a patient who screens negative for depression can still be carrying a serious anxiety disorder that is shaping their sleep, their physical symptoms, and how often they land in your office. If your intake asks only about mood, that person reads as fine. Adding a brief anxiety measure, like the companion questionnaire this same research group built, turns a blind spot into a number your team can act on.
The treatment gap is the part worth sitting with. Roughly 41% of patients who had an anxiety disorder were getting no care for it. That is not mostly a treatment failure. It is a detection failure, people whose problem was never named in the room. A two-minute form does not fix that by itself, but it is a cheap, reliable way to surface the cases that would otherwise stay quiet.
Be honest about the limits. This was a sample of selected United States primary care clinics around 2005, so your own population may read differently, and the study measured detection and burden, not whether routine double screening improves outcomes down the line. A screen is also only a prompt: it flags a likely problem for a clinician to confirm, it does not diagnose and it does not decide a plan. What the evidence supports is plain and low-cost: looking for anxiety, not just depression, finds people you are otherwise missing.
The takeaway
- Anxiety was about as common as depression in this primary care sample, roughly one in five patients, and far more often untreated, so a depression-only screen leaves a large group uncounted.
- Consider pairing a brief validated anxiety measure with your depression screen at intake and at follow-up, so comorbid cases surface instead of hiding behind a normal mood score.
- Treat any elevated score as a signal for a clinician to look closer and confirm, not as a diagnosis or a finished plan.
This is the work Asendar™ was built for: collecting the same validated anxiety and depression scores between visits and keeping both in front of your team, so a patient who is sliding on one measure while looking steady on the other shows up while there is still time to act.
Start a 15-day free trial for your clinicTrack CoCM minutes, catch patients at risk of missing the code, export a billing packet. No card to start, $199/mo per clinician after the trial.